Posted jul 5, 2018

At LSC we specialise only in Life Sciences and always keep up to date with leading news, projects and all that’s going on in the industry. As the sector sees continued rapid growth it’s easy to miss some of the major announcements. To make things easier and to ensure you too are well informed we’ve selected and summarised this month’s top Irish Life Science industry news stories below.

Phibro Animal Health to establish new biotech facility in Sligo, creating up to 150 jobs

Phibro Animal Health have announced plans to establish a Biotech facility producing a range of innovative animal health vaccines on the IDA Ireland Finisklin Business Park in Sligo, creating up to 150 jobs over 5 years. A great vote of confidence for Sligo as the plant will be the company’s first biological manufacturing location in Europe and will allow Phibro to expand it’s presence here. Initially the manufacturing facility will focus on Phibro’s innovative line of vaccines for the treatment of a range of poultry diseases for sales globally. Full article >>

Henkel opens major European hub for 3D Printing technology in Tallaght

Henkel, the world’s largest manufacturer of adhesives announced the opening of it’s new Innovation and Interaction Centre for Additive Manufacturing (3D Printing) in Tallaght. The project is supported by IDA Ireland and is based on a 4 year investment plan with an estimated investment of €18 million to expand the company’s capabilities in R&D, application and product development at the existing Tallaght site. Upon completion in 2020, 40 highly skilled jobs are to be created to focus on developing new advanced materials for use in precision manufacturing industries such as Med Device and Aerospace.  Full article >>

Gilead Sciences invest €9.5m in Cork plant

Gilead Sciences have announced the opening of a new Quality Control lab at it’s Carrigtwohill plant in Cork following a €9.5 million investment. The Cork plant manufactures drugs for the treatment of HIV and hepatitis and currently accounts for 25% of Gilead’s total production of drugs in tablet form. This investment has facilitated the extension of the current quality control facility and is designed to boost solid oral drug production for Europe, the Middle East and Asia. Full article >>

LSC expands to new facility

Due to phenomenal growth in the Irish Life Sciences and LSC’s commitment to fulfilling resource demands across the sector we have expanded our Kinsale offices. At LSC our business has grown rapidly over the past few years and we are now in our 8th year of double digit growth. LSC are delighted to have been able to scale the business as required while maintaining a base in Kinsale.
Full article>>